Understanding the nanoscale structural changes can provide the physical state of cells/tissues. It has been now shown that increases in nanoscale structural alterations are associated with the progress of carcinogenesis in most of the cancer cases, including early carcinogenesis. Anti-cancerous therapies are intended for the growth inhibition of cancer cells; however, it is challenging to detect the efficacy of such drugs in early stages of treatment. A unique method to assess the impact of anti-cancerous drugs on cancerous cells/tissues is to probe the nanoscale structural alterations. In this paper, we study the effect of different anti-cancerous drugs on ovarian tumorigenic cells, using their nanoscale structural alterations as a biomarker. Transmission electron microscopy (TEM) imaging on thin cell sections is performed to obtain their nanoscale structures. The degree of nanoscale structural alterations of tumorigenic cells and anti-cancerous drug treated tumorigenic cells are quantified by using the recently developed inverse participation ratio (IPR) technique. Results show an increase in the degree of nanoscale fluctuations in tumorigenic cells relative to non-tumorigenic cells; then a nearly reverse of the degree of fluctuation of tumorigenic cells to that of non-tumorigenic cells, after the anticancerous drugs treatment. These results support that the effect of anti-cancerous drugs in cancer treatment can be quantified by using the degree of nanoscale fluctuations of the cells via TEM imaging. Potential applications of the technique for cancer treatment are also discussed.
I. Introduction:
TEM imaging and probing nanoscale changes in cancer: TEM imaging is a method where we can probe ~1 nm resolution within the sample, and this has been used for imaging of cells at the nanoscale to see the inner structures of the cells, in general, qualitatively. It has been established that the cancer progression is associated with the nanoscale structural alteration in a cell due to the rearrangements of the building blocks of the cell such as DNA, RNA, and lipids. Therefore, TEM imaging is a good modality to probe cancerous changes in cells at the nanoscale level. Furthermore, the recently developed light wave localization technique, 'inverse participation ratio' (IPR), has shown success in quantifying the degree of structural changes in one parameter, known as the degree of structural disorder [1, 2] . In particular, using the IPR method, a TEM image is used to construct a disordered 2D mass matrix, and from this we generate a 2D refractive index matrix. Optical waves are then solved for their eigenvalues and eigenfunctions using the refractive index matrix with closed boundary conditions. The light localization properties are measured by the average inverse participation ratio, <IPR>, and standard deviation of the IPR, σ(IPR), of the eigenfunctions of the light waves in these samples. It is shown that the degree of structural disorder is proportional to the <IPR> or σ(IPR) [3, 4] . Therefore, the <IPR> can be used as a measure of the degree of nanoscale structural disorder, and to monitor structural change in cells under diseases condition. The IPR method is a very versatile approach. The IPR method, using TEM imaging, has been recently generalized to study the structural changes in brain and colon cells in chronic alcoholism [5, 6] .
Furthermore, IPR method also extended to study the molecular specific (DNA, histone, etc.) structural changes in cells by using molecular specific fluorophores and confocal microscopy imaging [7, 8] .
Ovarian cancer:
Ovarian cancer (OC) ranks the 5 th in cancer related deaths among women and accounts for more deaths than any other cancer of female reproductive system. The American Cancer Society (ACS), estimated new cases of OC in USA in 2019 would be 22,530, whereas estimated deaths would be 14,000. Most OC cases are diagnosed at a very late stage, of which 51% are diagnosed as stage III and 29% are diagnosed as stage IV [9] . The exact cause that triggers OC is not clearly understood but there are several risk factors such as fertility therapy, late pregnancy, family history, hormone therapy after menopause etc. are associated with the development of OC. Metabolic alterations, suppression of tumor suppressor genes, oncogenic activations are also considered as triggering factors for OC initiation and progression of disease [10, 11] .
Although initially sensitive to chemotherapy treatment, however majority of the OC patients develop chemo resistant. 10 years survival rate for most patients of all stages of OC is ~30%. Development of chemoresistance, widespread disease during the time of diagnosis and tumor recurrence are the major challenges in the therapeutics of ovarian cancer [12] .
In this study, we are focusing on analyzing the impact of novel anti-cancerous drug treatment in the tumor forming OC cell line in vitro. HSulf-1 knockdown OV202 cells are selected for this study for their aggressive tumor forming ability and high proliferation rate [13, 14] . This method of analysis is aimed to understand the effect of anti-cancerous drugs on cells in the early phases of treatment. Here we propose a novel approach to assess the impact of anti-cancerous drugs in cancerous cells by quantifying the degree of nanoscale structural disorder.
II. Method:
Analytical However, for a self-sufficient and completeness of this paper, we will describe the IPR technique in brief.
The refractive index of a thin cell slice at a point n(x,y) with constant width dz has a voxel of Optical parameter refractive index n(x,y) of the scattering substances is linearly proportional to the mass density of a biological cell for the thin samples [1] [2] . Therefore, the intensity of a TEM images is linearly proportional to the mass, M, and refractive index of the voxel:
From this, we can calculate optical potential of the voxel point as εi(x,y) to generate an optical lattice:
Knowing the optical potential at every point, an Anderson disorder tight binding model TBM Hamiltonian [15] [16] [17] can be generated as follows:
Where |i> and |j> are the eigenvectors of i-th and j-th lattice sites, εi(x,y) or simply εi, is the i-th lattice site optical potential energy and t is the overlap integral between sites i and j. The eigenfunctions (Ei's)
can now be generated from the above Hamiltonian by its diagonalization. Finally, the average IPR value of the whole samples we can define as [1-4, 18,19] :
where Ei denotes the i-th eigenfunction of the Hamiltonian, N is the total number of potential points on the refractive index matrix (i.e., N=(L/dx) 2 ). It has been shown that the average IPR value, <IPR>, is proportional to the degree of structural disorder Ld=dn×lc, where dn is the std of the all n(x,y) point and lc is the spatial correlation decay length of the n(x,y) over the sample [1, 2] . Then, Ld as a biomarker, we study the structural properties of the ovarian cancer cells with anti-cancerous drug treatments. In particular, we expect an increase in the structural disorder with the growth of cancer, and the reversibility of the structural disorder when the cancerous cells are treated with anti-cancerous drug, if the nanoscale structural disorder is a good cancer stage biomarker.
III. Sample Preparation and TEM imaging
Ovarian normal and cancer cell lines: OV202 cell line is a low-passage primary ovarian cancer cell line established at the Mayo Clinic [13] . OV202 NTC (expressing HSulf-1) and Sh1 cells (HSulf-1 deficient)
are developed by Dr. Shridhar's group at Mayo Clinic and is described earlier elsewhere [14] .
Subcutaneous injection of OV202 Sh1 cells resulted in tumor formation in nude mice, whereas HSulf-1 expressing OV202 NTC cells did not form tumor [13] . 
IV. Results and discussions:
The TEM images of the ovarian cancer cells are obtained as described in the above section. IPR analyses were performed for the samples on 165nm165nm TEM images. IPR averaging over the single cells, as well as over the different cells, were performed for ensemble averaging. As discussed above, the average <IPR> and σ(IPR) value for each TEM image was calculated and provides the degree of the structural disorder strength at a defined length scale. In the figure, it can be seen that 
IV. Conclusions
The nanoscale mass-density fluctuations are quantified with the progression of carcinogenesis, as wells as the effects of two anti-cancerous drugs on non-tumor forming OV202NTC and tumor forming OV202Sh1 Earlier IPR analysis of a different cell line has verified the increase of nanoscale structural disorder with the progression of cancer [1, 2] . Based on the results presented, we investigate the potential applications of the IPR technique in measuring and quantifying the effectiveness of different anti-cancerous drugs on ovarian cancer treatment. This quantification of effectiveness of anti-cancerous drugs in ovarian cancer treatment could enhance better drugs treatment modalities at its earliest and helps to control the deadly ovarian cancer. Although this study is based on ovarian cancer, however, the technique can be applied to the varieties of cancers to assess the effectiveness of different anti-cancerous drugs in treatment.
